Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.8B |
| Enterprise Value | 1.98B |
| P/E Ratio | -109.22 |
| PEG Ratio | 0.48 |
| Price/Sales Ratio | 5.95 |
| Price/Book Ratio | 55.6 |
| Enterprise/Revenue | 6.71 |
| Enterprise/EBITDA | 57.33 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.06 |
| Operating Margin | 0.1 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.34 |
Income Statement
| Revenue | 272.3M |
| Revenue/Share | 7.22 |
| Gross Profit | 204.37M |
| EBITDA | 41.36M |
| Net Income | -5.14M |
| Diluted EPS | -0.14 |
Balance Sheet
| Total Cash | 94.64M |
| Total Cash/Share | 2.54 |
| Total Debt | 300.67M |
| Total Debt/Equity | 10.47 |
| Current Ratio | 2.48 |
| Book Value Per Share | 0.76 |
Price History
| 52-Week Change | 0 |
| 52-Week High | 27.7 |
| 52-Week Low | 24.9 |
| Moving Average 50 Days | 26.19 |
| Moving Average 200 Days | 26.36 |
Statistics
| Average Volume | 10,551 |
| Shares Outstanding | 51.65M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
